Evidence map›Paper›PMID 38150244›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2024

Management of Patients with Multidrug-Resistant Organisms in Outpatient Dialysis Facilities.

Mary Dittrich, Jeffrey Silberzweig, Jeffrey L Hymes, Jeff Giullian, Gopa Green, Leslie P Wong, Barry I Freedman, J Ganesh Bhat, Leslie Spry, Robert Taylor and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Mary DittrichU.S. Renal Care, Plano, Texas.ORCID 0000-0002-3671-9629
Jeffrey SilberzweigThe Rogosin Institute, Weill Cornell Medical College, New York, New York.ORCID 0000-0002-2381-7043
Jeffrey L HymesCare Delivery, Fresenius Kidney Care, Waltham, Massachusetts.ORCID 0000-0001-5540-131
Jeff GiullianDavita, Inc., Denver, Colorado.
Gopa GreenSatellite Healthcare, San Jose, California.ORCID 0009-0001-8687-1581
Leslie P WongIntermountain Health, Murray, Utah.ORCID 0009-0008-2133-5332
Barry I FreedmanHealth Systems Management, Inc., Tifton, Georgia.ORCID 0000-0003-0275-5530
J Ganesh BhatAtlantic Dialysis Management Services, New York, New York.ORCID 0000-0003-1066-4882
Leslie SpryFresenius Kidney Care, Waltham, Massachusetts.ORCID 0000-0002-2414-2690
Robert TaylorREACH/Dialysis Clinic, Inc., Nashville, Tennessee.
Richard SpechCenters for Dialysis Care, Cleveland, Ohio.
Raghu DurvasulaPuget Sound Kidney Centers, Everett, Washington.
Sky R BlueSawtooth Epidemiology and Infectious Diseases, Boise, Idaho.ORCID 0009-0006-4430-3881
Fresenius Medical Care (United States) · USCornell University · USDaVita Clinical Research (United States) · USIntermountain Healthcare · USNorthwest Kidney Centers · USRealistic Education in Action Coalition to Foster Health · USRenal Associates P. A. · USSatellite Healthcare (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38150244
PMCPMC11108247
OpenAlexW4390265231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.